Advice

Following a full submission:

levonorgestrel (Kyleena®) is accepted for use within NHS Scotland.

Indication under review: contraception for up to 5 years.

A phase III, open-label, randomised study confirmed the contraceptive efficacy of levonorgestrel 19.5mg intrauterine delivery system according to the Pearl Index.

Download detailed advice222KB (PDF)

Download

Medicine details

Medicine name:
levonorgestrel (Kyleena)
SMC ID:
1299/18
Indication:
Contraception for up to 5 years.
Pharmaceutical company
Bayer Plc
BNF chapter
Obstetrics, gynaecology, and urinary-tract disorders
Submission type
Full
Status
Accepted
Date advice published:
12 February 2018